Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Asia Oceania Journal of Nuclear Medicine & Biology|July 13, 2018
A Comparison of 2D and 3D Kidney Absorbed Dose Measures in Patients Receiving 177Lu-DOTATATEKathy P Willowson, HyunJu Ryu, Price Jackson, et al.
Medical Physics|July 3, 2015
(90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fractionThomas Carlier, Kathy P Willowson, Eugene Fourkal, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|August 26, 2017
Changing Therapeutic Paradigms: Predicting mCRC Lesion Response to Selective Internal Radionuclide Therapy (SIRT) based on Critical Absorbed Dose Thresholds: A Case StudyKathy P Willowson, Elizabeth J Bernard, Richard Maher, et al.
Physics in Medicine and Biology|June 18, 2019
Performance evaluation of quantitative SPECT/CT using NEMA NU 2 PET methodologyHyunJu Ryu, Steven R Meikle, Kathy P Willowson, et al.
EJNMMI Physics|December 21, 2018
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE ('Lutate') therapyKathy P Willowson, Enid Eslick, Hyunju Ryu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2020
Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofeninKathy P Willowson, Geoffrey P Schembri, Elizabeth J Bernard, et al.
Seminars in Nuclear Medicine|October 6, 2010
SPECT/CT in V/Q scanningPaul J Roach, Denis J Gradinscak, Geoffrey P Schembri, et al.
World Journal of Nuclear Medicine|November 12, 2025
Theranostic Radioembolization: Radiation Dosimetry-Guided Treatment Planning and DeliveryDale L Bailey, Elizabeth J Bernard, Richard Maher, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|December 2, 2016
In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-OctreotateDale L Bailey, Thomas M Hennessy, Kathy P Willowson, et al.
Pageof 13